Follow the HLB생명과학 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, HLB생명과학 has published 31 reports. Market capitalisation: €234.6bn. The latest transaction was reported on 11 March 2026 (Other). Among the most active insiders: HLB. The full history is accessible without an account.
31
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HLB생명과학 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.